{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:10:21Z","timestamp":1785409821816,"version":"3.56.0"},"reference-count":53,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda, M\u00e9xico","doi-asserted-by":"crossref","award":["236767"],"award-info":[{"award-number":["236767"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]},{"award":["236767"],"award-info":[{"award-number":["236767"]}],"id":[{"id":"https:\/\/ror.org\/059ex5q34","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer is the second leading cause of death worldwide. Mutations in the TP53 gene lead to a loss of tumor suppressor function and an oncogenic gain of function for the protein, resulting in a more invasive, metastatic, and chemoresistant phenotype. Diverse structural studies have demonstrated that mutant p53 core domain unfolding is not irreversible. Thus, reactivation toward its wild-type-like conformation or inactivation of its mutant p53 capacities may restore the expression of genes in its tumor suppressor pathways, resulting in enhanced responses to current therapies. Resveratrol (3,4\u2032,5-trihydroxy-trans-stilbene) is a phytoalexin naturally found in more than 70 plant species that has widely proven antiproliferative and pro-apoptotic properties, as well as a capacity to reverse multidrug resistance in various cancer types. Interestingly, it has recently been demonstrated that resveratrol directly interacts with the p53 core domain and reduces mutant p53 aberrant aggregation. In this context, our study aims to elucidate whether resveratrol may induce antiproliferative and pro-apoptotic pathways regardless of a mutant background. We observed that resveratrol has an antiproliferative effect in cancer cells, independent of p53 status, and leads to apoptosis after 48 h of treatment. Resveratrol also induces the expression of p53 tumor suppressor target genes, which are involved in cell cycle arrest and apoptosis. Even though the previous effects are more significant in cells expressing wild-type p53, resveratrol drastically sensitizes all cancer cell lines, regardless of p53 status, to cisplatin treatment, making it a promising enhancer compound to overcome chemoresistance associated with p53.<\/jats:p>","DOI":"10.3390\/ijms27104481","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:40:31Z","timestamp":1779115231000},"page":"4481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reactivation of P53 Antiproliferative and Pro-Apoptotic Pathways by Resveratrol in Mutant P53 Cancer Cell Lines"],"prefix":"10.3390","volume":"27","author":[{"given":"Andrea","family":"Acosta-Dent","sequence":"first","affiliation":[{"name":"Departamento de Gen\u00e9tica y Biolog\u00eda Molecular, Centro de Investigaci\u00f3n y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Garc\u00eda-Villa","sequence":"additional","affiliation":[{"name":"Departamento de Gen\u00e9tica y Biolog\u00eda Molecular, Centro de Investigaci\u00f3n y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cotino-N\u00e1jera","sequence":"additional","affiliation":[{"name":"Departamento de Gen\u00e9tica y Biolog\u00eda Molecular, Centro de Investigaci\u00f3n y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4546-5863","authenticated-orcid":false,"given":"Solangy","family":"Lizcano-Meneses","sequence":"additional","affiliation":[{"name":"Departamento de Gen\u00e9tica y Biolog\u00eda Molecular, Centro de Investigaci\u00f3n y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Alejandro","family":"Lagunas-Rangel","sequence":"additional","affiliation":[{"name":"Departamento de Gen\u00e9tica y Biolog\u00eda Molecular, Centro de Investigaci\u00f3n y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efra\u00edn","family":"Garrido-Guerrero","sequence":"additional","affiliation":[{"name":"Departamento de Gen\u00e9tica y Biolog\u00eda Molecular, Centro de Investigaci\u00f3n y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9583-3790","authenticated-orcid":false,"given":"Jos\u00e9","family":"D\u00edaz-Ch\u00e1vez","sequence":"additional","affiliation":[{"name":"Subdirecci\u00f3n de Investigaci\u00f3n B\u00e1sica, Instituto Nacional de Cancerolog\u00eda, Av. San Fernando No. 22, Secci\u00f3n XVI, Tlalpan, Mexico City 14080, Mexico"},{"name":"Tecnol\u00f3gico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Calle del Puente #222, Col. San Bartolo el Chico, Tlalpan, Mexico City 14380, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Gariglio","sequence":"additional","affiliation":[{"name":"Departamento de Gen\u00e9tica y Biolog\u00eda Molecular, Centro de Investigaci\u00f3n y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41698-019-0079-0","article-title":"Accumulation of Genetic and Epigenetic Alterations in Normal Cells and Cancer Risk","volume":"3","author":"Takeshima","year":"2019","journal-title":"npj Precis. Onc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"P53: 800 Million Years of Evolution and 40 Years of Discovery","volume":"20","author":"Levine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/cdd.2017.171","article-title":"Deconstructing Networks of P53-Mediated Tumor Suppression in Vivo","volume":"25","author":"Kaiser","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of P53 in Cell Death and Human Cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2641","article-title":"P53 Mutations in Cancer","volume":"15","author":"Muller","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41419-021-03497-y","article-title":"Mutant P53 Promotes RCP-Dependent Chemoresistance Coinciding with Increased Delivery of P-Glycoprotein to the Plasma Membrane","volume":"12","author":"Phatak","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000446361","article-title":"Mutant P53 Gain of Function and Chemoresistance: The Role of Mutant P53 in Response to Clinical Chemotherapy","volume":"62","author":"He","year":"2017","journal-title":"Chemotherapy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/onc.2014.359","article-title":"Functional Interplay between MDM2, P63\/P73 and Mutant P53","volume":"34","author":"Stindt","year":"2015","journal-title":"Oncogene"},{"key":"ref_10","first-page":"6","article-title":"P53: The Most Frequently Altered Gene in Human Cancers","volume":"3","author":"Vogelstein","year":"2010","journal-title":"Nat. Educ."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/humu.22552","article-title":"TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade","volume":"35","author":"Leroy","year":"2014","journal-title":"Hum. Mutat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41418-022-00989-y","article-title":"Mutant P53: It\u2019s Not All One and the Same","volume":"29","author":"Kennedy","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","article-title":"Mutant P53 as a Guardian of the Cancer Cell","volume":"26","author":"Mantovani","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Alvarado-Ortiz, E., De La Cruz-L\u00f3pez, K.G., Becerril-Rico, J., Sarabia-S\u00e1nchez, M.A., Ortiz-S\u00e1nchez, E., and Garc\u00eda-Carranc\u00e1, A. (2021). Mutant P53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.607670"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/nar\/gkm099","article-title":"Cancer-Derived P53 Mutants Suppress P53-Target Gene Expression\u2014Potential Mechanism for Gain of Function of Mutant P53","volume":"35","author":"Vikhanskaya","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1038\/sj.onc.1204724","article-title":"The C-Terminus of Mutant P53 Is Necessary for Its Ability to Interfere with Growth Arrest or Apoptosis","volume":"20","author":"Sigal","year":"2001","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eaao4170","DOI":"10.1126\/scisignal.aao4170","article-title":"Mutant and Wild-Type P53 Form Complexes with P73 upon Phosphorylation by the Kinase JNK","volume":"11","author":"Wolf","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1073\/pnas.1913919116","article-title":"Mutant P53 Antagonizes P63\/P73-Mediated Tumor Suppression via Notch1","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e61487","DOI":"10.7554\/eLife.61487","article-title":"Zinc Shapes the Folding Landscape of P53 and Establishes a Pathway for Reactivating Structurally Diverse Cancer Mutants","volume":"9","author":"Blanden","year":"2020","journal-title":"eLife"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100820","DOI":"10.1016\/j.isci.2020.100820","article-title":"Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant P53 Amyloid Oligomers","volume":"23","author":"Pedrote","year":"2020","journal-title":"iScience"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1038\/onc.2014.296","article-title":"P53 Protein Aggregation Promotes Platinum Resistance in Ovarian Cancer","volume":"34","author":"Soteras","year":"2015","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc.2017.109","article-title":"Targeting Mutant P53 for Efficient Cancer Therapy","volume":"18","author":"Bykov","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhu, G., Pan, C., Bei, J.-X., Li, B., Liang, C., Xu, Y., and Fu, X. (2020). Mutant P53 in Cancer Progression and Targeted Therapies. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.595187"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/d41586-022-00565-x","article-title":"P53: An Anticancer Protein\u2019s Chequered Past and Promising Future","volume":"603","author":"Eisenstein","year":"2022","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/joim.12336","article-title":"Pharmacological Reactivation of P53 as a Strategy to Treat Cancer","volume":"277","author":"Selivanova","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.phrs.2013.11.003","article-title":"Disarming Mutant P53 Oncogenic Function","volume":"79","author":"Girardini","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"837042","DOI":"10.1155\/2015\/837042","article-title":"Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans","volume":"2015","author":"Gambini","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The Therapeutic Potential of Resveratrol: A Review of Clinical Trials","volume":"1","author":"Berman","year":"2017","journal-title":"npj Precis. Onc"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M.K., Arfuso, F., Kumar, A.P., Bishayee, A., and Ahn, K.S. (2017). The Role of Resveratrol in Cancer Therapy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122589"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cotino-N\u00e1jera, S., Herrera, L.A., Dom\u00ednguez-G\u00f3mez, G., and D\u00edaz-Ch\u00e1vez, J. (2023). Molecular Mechanisms of Resveratrol as Chemo and Radiosensitizer in Cancer. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1287505"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hernandez-Valencia, J., Garcia-Villa, E., Arenas-Hernandez, A., Garcia-Mena, J., Diaz-Chavez, J., and Gariglio, P. (2018). Induction of P53 Phosphorylation at Serine 20 by Resveratrol Is Required to Activate P53 Target Genes, Restoring Apoptosis in MCF-7 Cells Resistant to Cisplatin. Nutrients, 10.","DOI":"10.3390\/nu10091148"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ferraz Da Costa, D.C., Casanova, F.A., Quarti, J., Malheiros, M.S., Sanches, D., Dos Santos, P.S., Fialho, E., and Silva, J.L. (2012). Transient Transfection of a Wild-Type P53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048746"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fu, Y., Chang, H., Peng, X., Bai, Q., Yi, L., Zhou, Y., Zhu, J., and Mi, M. (2014). Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy via Suppressing Wnt\/\u03b2-Catenin Signaling Pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102535"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1302\/2046-3758.33.2000226","article-title":"The Effect of Resveratrol on Normal and Osteoarthritic Chondrocyte Metabolism","volume":"3","author":"Kim","year":"2014","journal-title":"Bone Jt. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1038\/cddiscovery.2015.61","article-title":"Resveratrol Chemosensitizes HER-2-Overexpressing Breast Cancer Cells to Docetaxel Chemoresistance by Inhibiting Docetaxel-Mediated Activation of HER-2\u2013Akt Axis","volume":"1","author":"Vinod","year":"2015","journal-title":"Cell Death Discov."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16634","DOI":"10.1002\/jcb.28922","article-title":"The Role of Resveratrol in Bone Marrow-derived Mesenchymal Stem Cells from Patients with Osteoporosis","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Saqib, U., Kelley, T.T., Panguluri, S.K., Liu, D., Savai, R., Baig, M.S., and Sch\u00fcrer, S.C. (2018). Polypharmacology or Promiscuity? Structural Interactions of Resveratrol with Its Bandwagon of Targets. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01201"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/s41598-017-18943-1","article-title":"Molecular Mechanism of Resveratrol\u2019s Lipid Membrane Protection","volume":"8","author":"Fei","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"38186","DOI":"10.1038\/srep38186","article-title":"Resveratrol Serves as a Protein-Substrate Interaction Stabilizer in Human SIRT1 Activation","volume":"6","author":"Hou","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"29112","DOI":"10.18632\/oncotarget.25631","article-title":"Resveratrol Prevents P53 Aggregation in Vitro and in Breast Cancer Cells","volume":"9","author":"Campos","year":"2018","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ha, J.-H., Prela, O., Carpizo, D.R., and Loh, S.N. (2022). P53 and Zinc: A Malleable Relationship. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.895887"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102230","DOI":"10.1016\/j.cbpa.2022.102230","article-title":"Inhibition of P53 Protein Aggregation as a Cancer Treatment Strategy","volume":"72","author":"Kwan","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s12011-023-03758-1","article-title":"Resveratrol Inhibits Zinc Deficiency-Induced Mitophagy and Exerts Cardiac Cytoprotective Effects","volume":"202","author":"Wang","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"C632","DOI":"10.1152\/ajpcell.00139.2009","article-title":"Effect of Resveratrol and Zinc on Intracellular Zinc Status in Normal Human Prostate Epithelial Cells","volume":"297","author":"Zhang","year":"2009","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bukowski, K., Kciuk, M., and Kontek, R. (2020). Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093233"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.18632\/oncotarget.13475","article-title":"The Role of P53 in Cancer Drug Resistance and Targeted Chemotherapy","volume":"8","author":"Hientz","year":"2017","journal-title":"Oncotarget"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.2174\/1568026621666211105093658","article-title":"Resveratrol and Colorectal Cancer: A Molecular Approach to Clinical Researches","volume":"21","author":"Vernousfaderani","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1080\/15384101.2019.1688951","article-title":"Mutant P53 Drives Cancer Chemotherapy Resistance Due to Loss of Function on Activating Transcription of PUMA","volume":"18","author":"Huang","year":"2019","journal-title":"Cell Cycle"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s42004-024-01289-x","article-title":"Oncogenic P53 Triggers Amyloid Aggregation of P63 and P73 Liquid Droplets","volume":"7","author":"Petronilho","year":"2024","journal-title":"Commun. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1038\/sj.onc.1206511","article-title":"Characterization of the P53 Mutants Ability to Inhibit P73\u03b2 Transactivation Using a Yeast-Based Functional Assay","volume":"22","author":"Monti","year":"2003","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"\u010cechov\u00e1, J., Coufal, J., Jagelsk\u00e1, E.B., Fojta, M., and Br\u00e1zda, V. (2018). P73, like Its P53 Homolog, Shows Preference for Inverted Repeats Forming Cruciforms. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195835"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:30:22Z","timestamp":1779165022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104481"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104481","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}